The experience of albinism in France: a qualitative study on dyads of parents and their adult child with albinism
-
Published:2024-01-29
Issue:1
Volume:22
Page:
-
ISSN:1741-7015
-
Container-title:BMC Medicine
-
language:en
-
Short-container-title:BMC Med
Author:
Fournier HugoORCID, Hasdenteufel Marie, Garrouteigt Constance, Perie Mathieu, Gliksohn Antoine, Jouanne Béatrice, Hadj-Rabia Smail, Arveiler Benoit, Morice-Picard Fanny, Quintard Bruno
Abstract
Abstract
Background
To date, almost no research on the psychosocial implications of albinism has been conducted in France and an exploration of albinism-related experiences could be beneficial, in order to better understand this condition. The aim of this study was to examine how French people with albinism and their parents live with and adapt to this condition in all the areas of their lives.
Methods
Semi-structured phone interviews were conducted with 9 parent-child dyads, each participating separately. Participants were recruited by convenience sampling, thanks to the combined efforts of a patient association (Genespoir) and professionals from the partner medical referral centers involved in the project. Dyads in which the individual with albinism had any comorbidity were excluded. The interviews were then transcribed and subjected to in-depth thematic analysis. Two codebooks were constructed in a mirrored process: one for people with albinism; the other for their parents. They were finally merged at the end of the coding step.
Results
Four main categories were identified: personal perceptions and social representations of albinism, difficulties and obstacles encountered by people with albinism, resources and facilitators, and the importance of parent-child functioning. The results indicated that experiences of stigmatization during childhood and adolescence are common and that people with albinism face challenges in adapting to certain obstacles related to their visual impairments (VI) (e.g., inability to drive a car; eye strain...). Parents emerged as one, if not as the main, source of support for people with albinism throughout their development. Although external support systems exist to assist them in various aspects of their lives, some of them primarily rely on their own personal resources to cope.
Conclusions
This research highlights the importance of a systemic and transdisciplinary approach to make sure families receive the support that best meets their needs.
Funder
Fondation Maladies Rares
Publisher
Springer Science and Business Media LLC
Reference146 articles.
1. Lasseaux E, Neveu MM, Fiore M, Morice-Picard F, Arveiler B. Albinism. In: Black GCM, Ashworth JL, Sergouniotis PI, editors. Clinical ophthalmic genetics and genomics. San Diego, CA: Academic Press; 2022. p. 393–402 ISBN 978-0128139448. 2. Pennamen P, Tingaud-Sequeira A, Gazova I, Keighren M, McKie L, Marlin S, Gherbi Halem S, Kaplan J, Delevoye C, Lacombe D, Plaisant C, Michaud V, Lasseaux E, Javerzat S, Jackson I, Arveiler B. Dopachrome tautomerase variants in patients with oculocutaneous albinism. Genet Med. 2021;23(3):479–87. https://doi.org/10.1038/s41436-020-00997-8. 3. Pennamen P, Le L, Tingaud-Sequeira A, Fiore M, Bauters A, Van Duong Béatrice N, Coste V, Bordet JC, Plaisant C, Diallo M, Michaud V, Trimouille A, Lacombe D, Lasseaux E, Delevoye C, Morice-Picard F, Delobel B, Marks MS, Arveiler B. BLOC1S5 pathogenic variants cause a new type of Hermansky-Pudlak syndrome. Genet Med. 2020;22(10):1613–22. https://doi.org/10.1038/s41436-020-0867-5. 4. Lasseaux E, Plaisant C, Michaud V, Pennamen P, Trimouille A, Gaston L, Monfermé S, Lacombe D, Rooryck C, Morice-Picard F, Arveiler B. Molecular characterization of a series of 990 index patients with albinism. Pigment Cell Melanoma Res. 2018;31(4):466–74. https://doi.org/10.1111/pcmr.12688. 5. Mauri L, Manfredini E, Del Longo A, Veniani E, Scarcello M, Terrana R, Radaelli AE, Calò D, Mingoia G, Rossetti A, Marsico G, Mazza M, Gesu GP, Cristina Patrosso M, Penco S, Piozzi E, Primignani P. Clinical evaluation and molecular screening of a large consecutive series of albino patients. J Hum Genet. 2017;62(2):277–90. https://doi.org/10.1038/jhg.2016.123.
|
|